Department of Otorhinolaryngology, Head and Neck Surgery, Erasmus University Medical Center, Rotterdam, Netherlands; Erasmus Medical Center Cancer Institute, Erasmus University Medical Center, Rotterdam, Netherlands.
Department of Orthopedic Surgery, Isala Hospital, Zwolle, Netherlands.
Lancet Oncol. 2021 May;22(5):e186-e195. doi: 10.1016/S1470-2045(20)30600-8. Epub 2021 Mar 23.
Fluorescence-guided surgery is an intraoperative optical imaging method that provides surgeons with real-time guidance for the delineation of tumours. Currently, in phase 1 and 2 clinical trials, evaluation of fluorescence-guided surgery is primarily focused on its diagnostic performance, although the corresponding outcome variables do not inform about the added clinical benefit of fluorescence-guided surgery and are challenging to assess objectively. Nonetheless, the effect of fluorescence-guided surgery on intraoperative decision making is the most objective outcome measurement to assess the clinical value of this imaging method. In this Review, we explore the study designs of existing trials of fluorescence-guided surgery that allow us to extract information on potential changes in intraoperative decision making, such as additional or more conservative resections. On the basis of this analysis, we offer recommendations on how to report changes in intraoperative decision making that result from fluorescence imaging, which is of utmost importance for the widespread clinical implementation of fluorescence-guided surgery.
荧光引导手术是一种术中光学成像方法,可为外科医生提供肿瘤边界的实时指导。目前,在 1 期和 2 期临床试验中,荧光引导手术的评估主要集中在其诊断性能上,尽管相应的结果变量并不能说明荧光引导手术的附加临床益处,并且难以客观评估。尽管如此,荧光引导手术对术中决策的影响是评估这种成像方法临床价值的最客观的结果测量。在这篇综述中,我们探讨了现有的荧光引导手术临床试验的设计,这些设计使我们能够提取关于术中决策潜在变化的信息,例如额外或更保守的切除。在此分析的基础上,我们就如何报告荧光成像引起的术中决策变化提出了建议,这对于荧光引导手术的广泛临床应用至关重要。